TXA is an inexpensive (approximately $3 per gram) and widely available antifibrinolytic medication with an established safety ...

Clinicians and health system leaders met in Cleveland, Ohio, on October 23, 2025, to share improvements to value-based care ...

“In our real-world experience, [Yescarta] in relapsed or refractory follicular lymphoma showed durable responses and a ...

The advisory issued on Dec. 25, 2025 is to alert clinicians and laboratories to an increase in pulmonary and disseminated ...

The use of an older medication at the time of surgery can reduce the need for red blood cell transfusions, according to a ...

Objective Systemic corticosteroids for 5–7 days are standard care for asthma exacerbations, but the optimal duration and ...

CSI Focus D-HF provides a comprehensive overview of device-based therapy in heart failure, including advancements in ventricle restoration strategies, device-based strategies to improve cardiac output ...

Clinical utility data for Nodify Lung® tests to be presented at North American Conference on Lung Cancer (NACLC) highlighting potential for ...

Trevi Therapeutics stock (TRVI) earns a Buy rating as Haduvio advances toward phase 3 for chronic cough in IPF. Read the full ...

CytoAgents, Inc., a clinical-stage biotechnology company developing CTO1681, a novel, steroid sparing inhibitor of prostaglandin mediated inflammation, announced today that preliminary safety data ...

Ethiopia: A rare case of isolated laryngeal tuberculosis (TB) in an otherwise healthy young woman has been reported in BMC ...